Adcock Ingram gives up on Cipla Medpro

Adcock Ingram abandoned a takeover of Cipla Medpro South Africa after discovering that India's Cipla may cancel a supply agreement with its smaller rival, casting doubt over the merits of the bid. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.